Home Tags Pharmaceuticals

Tag: Pharmaceuticals

South Africa: Pfizer denies over-charging for cancer drugs

US drugmaker Pfizer has denied allegations it overcharged for cancer medicines in South Africa following an investigation launched on Tuesday by the country’s competition...

Sharing, Samples, and Generics: An Antitrust Framework

Posted by Social Science Research Network Sharing, Samples, and Generics: An Antitrust Framework By Michael A. Carrier (Rutgers Law School) Abstract:     Rising drug prices are in...

US: EpiPen maker may have overcharged taxpayers by $1.27 billion

Mylan Pharmaceuticals, the maker of EpiPens for allergy sufferers, may have overcharged taxpayers as much as $1.27 billion by misclassifying their life-saving devices under...

NDRC’s Enforcement In 2016

By Susan Ning, Kate Peng, Sibo Gao and Ting Gong - Since the enactment of the Anti-monopoly Law (“AML”) in 2008, China’s AML enforcement has gained...

US: Fed lawsuit accuses 3 insulin manufacturers of conspiring to raise...

A federal lawsuit is accusing three of the biggest drug manufacturers of insulin of conspiring together to raise their prices, but the pharmaceutical companies...

An Examination of the Proposed Teva-Allergan Merger

By William S. Comanor & Diana L. Moss -  The proposed Teva-Allergan merger joins the largest generic pharmaceutical company in the world, Teva Pharmaceuticals, with an...

Feb-09(2)

In this issue: The EC Pharmaceutical Sector Inquiry   Kent Bernard, Feb 23, 2009 Solving the Wrong Problem The Preliminary Report on the EC Pharmaceutical Sector Inquiry: What...

JUL-12(2)

The final issue in our health series brings in a global perspective. Four of our authors take a look at the EU approach to...

JUN-12(2)

With the Supreme Court ruling on Obama Care, much of the business world is focused on healthcare. In honor of that attention, we decided...

Nov-08(1)

The EC Pharmaceutical Report Kent Bernard, Nov 12, 2008 The 2008 EC Sector Inquiry Regarding Pharmaceuticals: What Does It Mean from a Research-Based Company Perspective? A sector...

News

Antitrust Mix by CPI